Sell4

Enova International, Inc.

ENVA

Total Value

$3.4M

Net $2.6M sold

Filing Date

Oct 29, 2026

3 transactions

Sales

$2.6M

3 transactions

Trade Summary

On Oct 27, 2026, Cunningham Steven E, Insider, sold $3.4M of Enova International, Inc. (ENVA) across 3 transactions. The filing covers Common stock, par value $0.00001 per share and reflects net selling of $2.6M. Reported prices ranged from $31.98 to $172.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Price at the Time of the Trade

ENVA daily price with the insider's sale marked at $172.00.

Sold near the 6-month low · about level with today's price.

Price data is delayed and provided for context only — not investment advice.

Insider Information

Name: Cunningham Steven E
Role: Insider
Location: CHICAGO, IL

Filing Details

Filing Date: Oct 29, 2026
Transaction Date: Oct 27, 2026
Accession Number: 0001193125-26-438275
Form Type: 4
Net Trading Amount: -$2.6M

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Oct 27, 2026	Common stock, par value $0.00001 per share	7,391	$31.98	Exercise	$236.4K
Oct 27, 2026	Common stock, par value $0.00001 per share	7,391	$172.00	Sale	$1.3M
Oct 27, 2026	Common stock, par value $0.00001 per share	3,758	$35.75	Exercise	$134.3K
Oct 27, 2026	Common stock, par value $0.00001 per share	3,758	$172.00	Sale	$646.4K
Oct 27, 2026	Common stock, par value $0.00001 per share	4,156	$172.00	Sale	$714.8K

Derivative Transactions

Date	Security	Shares	Exercise Price	Type	Value
Oct 27, 2026	ENVA derivative	7,391	$31.98	Exercise	$236.4K
Oct 27, 2026	ENVA derivative	3,758	$35.75	Exercise	$134.3K

Want live alerts when Cunningham Steven E trades again?

Download Insider Trades to track ENVA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
(F2)The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
(F3)The options vested in substantially equal one-third increments on each of the following dates: February 3, 2023, February 3, 2024, and February 3, 2025.
(F4)The options vested in substantially equal one-third increments on each of the following dates: February 4, 2023, February 4, 2024, and February 4, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Steven E

(Last)

(First)

(Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO

60604

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock, par value $0.00001 per share	10/27/2026		M		7,391	A	$31.98	130,336	D
Common stock, par value $0.00001 per share	10/27/2026		S		7,391	D	$172	122,945	D
Common stock, par value $0.00001 per share	10/27/2026		M		3,758	A	$35.75	126,703	D
Common stock, par value $0.00001 per share	10/27/2026		S		3,758	D	$172	122,945	D
Common stock, par value $0.00001 per share	10/27/2026		S		4,156	D	$172	118,789	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right to buy) with limited SAR⁽¹⁾⁽²⁾	$31.98	10/27/2026		M			7,391	⁽³⁾	08/03/2028	Common stock; par value $0.00001 per share	7,391	$0	0	D
Non-Qualified Stock Option (right to buy) with limited SAR⁽¹⁾⁽²⁾	$35.75	10/27/2026		M			3,758	⁽⁴⁾	11/04/2028	Common stock; par value $0.00001 per share	3,758	$0	7,514	D

Explanation of Responses:

1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

3. The options vested in substantially equal one-third increments on each of the following dates: February 3, 2023, February 3, 2024, and February 3, 2025.

4. The options vested in substantially equal one-third increments on each of the following dates: February 4, 2023, February 4, 2024, and February 4, 2025.

	/s/ Sean Rahilly, as attorney in fact	10/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001193125-26-438275.

Enova International, Inc.

Trade Summary

Price at the Time of the Trade

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Derivative Transactions

Want live alerts when Cunningham Steven E trades again?

Footnotes

SEC Form 4

SEC Filing

Price at the Time of the Trade

SEC Form 4